Albaconazole is an experimental triazole antifungal agent being investigated in clinical trials for the treatment of onychomycosis, a common fungal infection affecting the nails. This pharmaceutical functions… Read more

![Chemical structure of (αR)-α-[(1R)-1-Aminoethyl]-α-(2,4-difluorophenyl)-1H-1,2,4-triazole-1-ethanol Hydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1391468-05-5-R-1R-1-Aminoethyl-24-difluorophenyl-1H-124-triazole-1-ethanol-Hydrochloride.png&w=3840&q=75)




Albaconazole is an experimental triazole antifungal agent being investigated in clinical trials for the treatment of onychomycosis, a common fungal infection affecting the nails. This pharmaceutical functions by inhibiting fungal cytochrome P450 enzymes, effectively disrupting the ergosterol synthesis required for maintaining fungal cell membrane integrity. This category provides comprehensive reference standards for the Albaconazole active pharmaceutical ingredient, alongside related metabolites, such as 6-hydroxy-Albaconazole, and degradation products. These materials are essential for pharmaceutical laboratories conducting rigorous impurity profiling, method validation, and stability testing. Additionally, the availability of stable isotope-labelled compounds, such as deuterated Albaconazole, supports precise quantitative analysis, particularly when serving as internal standards in liquid chromatography-mass spectrometry (LC-MS) applications, ensuring the accuracy and reliability of analytical data throughout the drug development process.